导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 1.75% | 491/1050 |
| 近一周 | -2.07% | 443/1104 |
| 近一月 | -5.02% | 611/1102 |
| 近一季 | -8.47% | 600/1092 |
| 近半年 | -2.86% | 508/1070 |
| 近一年 | 4.49% | 482/1018 |
| 近两年 | 43.85% | 547/926 |
| 近三年 | 27.65% | 410/834 |
| 成立以来 | 60.79% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.37% 458/1070 |
17.14% 423/1101 |
- - |
- - |
| 2025 | 19.76% 674/1065 |
2.18% 633/1014 |
0.16% 667/1038 |
17.43% 682/1050 |
-0.36% 476/1065 |
| 2024 | 14.00% 197/1011 |
3.12% 163/960 |
-0.08% 313/983 |
14.52% 262/991 |
-3.39% 563/1011 |
| 2023 | -10.64% 353/952 |
2.85% 457/880 |
-1.10% 244/895 |
-4.48% 267/915 |
-8.03% 761/952 |
| 2022 | -21.50% 390/867 |
-9.17% 89/773 |
6.34% 444/806 |
-14.89% 558/845 |
-4.51% 622/867 |
| 2021 | 4.25% 314/740 |
-3.62% 286/580 |
17.24% 203/659 |
-5.14% 359/704 |
-2.74% 535/740 |
| 2020 | 50.90% 235/554 |
-3.34% 241/419 |
20.56% 277/466 |
12.72% 188/517 |
14.88% 207/554 |
| 2019 | 34.21% 264/410 |
24.04% 778/1146 |
-2.64% 559/1228 |
0.27% 325/390 |
10.83% 140/410 |
| 2018 | -26.51% 168/349 |
- - |
-9.55% 465/990 |
-5.19% 470/1000 |
-12.19% 614/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长信量化多策略股票C VS. 东吴新产业精选股票A(580008) |